Efficacy of omalizumab in cat-allergic patients with moderate-to-severe persistent asthma

By Massanari Marc   Kianifard Farid   Zeldin Robert K.   Geba Gregory P.  

Allergy and Asthma Proceedings, Vol. 30, Iss. 5, 2009-09 ,pp. : 534-539

OceanSide Publications, Inc

Access to resources Recommend Favorite

Omalizumab: An update on efficacy and safety in moderate-to-severe allergic asthma

By Chipps Bradley E.   Figliomeni Maria   Spector Sheldon  

Allergy and Asthma Proceedings, Vol. 33, Iss. 5, 2012-09 ,pp. : 377-385

OceanSide Publications, Inc

Access to resources Recommend Favorite

Nebulized dehydroepiandrosterone-3-sulfate improves asthma control in the moderate-to-severe asthma results of a 6-week, randomized, double-blind, placebo-controlled study

By Wenzel Sally E.   Robinson Cynthia B.   Leonard Joanne M.   Panettieri Reynold A.  

Allergy and Asthma Proceedings, Vol. 31, Iss. 6, 2010-11 ,pp. : 461-471

OceanSide Publications, Inc

Access to resources Recommend Favorite

Pairwise Comparison of Levalbuterol versus Racemic Albuterol in the Treatment of Moderate-to-Severe Asthma

By Pleskow Warren W.   Nelson Harold S.   Schaefer Kendyl   Claus Raymond   Roach James M.  

Allergy and Asthma Proceedings, Vol. 25, Iss. 6, 2004-11 ,pp. : 429-436

OceanSide Publications, Inc

Access to resources Recommend Favorite

Changes in asthma control, work productivity, and impairment with omalizumab: 5-year EXCELS study results

By Zazzali James L.   Raimundo Karina P.   Trzaskoma Benjamin   Rosén Karin E.   Schatz Michael  

Allergy and Asthma Proceedings, Vol. 36, Iss. 4, 2015-07 ,pp. : 283-292

OceanSide Publications, Inc

Access to resources Recommend Favorite